Systemic sclerosis and prevalence of monoclonal immunoglobulin

Autoimmunity Reviews

Volumn 13, Issue 12, 2014, Pages 1189-1194

  Trad, Salim ^a,f   Nosbaum, Audrey ^a   Musset, Lucile ^a   Ghillani Dalbin, Pascale ^a   Launay, David ^b   Costedoat Chalumeau, Nathalie ^a,c   Saadoun, David ^a,c   Cabane, Jean ^a,c   Hachulla, Eric ^b   Hanslik, Thomas ^a,d   Frances, Camille ^c,e  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e HÔPITAL TENON   (France)

^f HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Autoimmunity; Capillary electrophoresis; Immunofixation; Monoclonal gammopathy; Mortality; Systemic sclerosis

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; MITOCHONDRION ANTIBODY; PARAPROTEIN; MONOCLONAL ANTIBODY;

ADULT; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PREVALENCE; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; REVIEW; SYSTEMIC SCLEROSIS; WALDENSTROEM MACROGLOBULINEMIA; CAPILLARY; IMMUNOLOGY; PHENOTYPE; SCLERODERMA, SYSTEMIC;

ANTIBODIES, MONOCLONAL; CAPILLARIES; HUMANS; PHENOTYPE; PREVALENCE; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC;

EID: 84908894167     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.08.016     Document Type: Review

References (23)

1. Foti R., Leonardi R., Rondinone R., Di Gangi M., Leonetti C., Canova M., et al. Scleroderma-like disorders. Autoimmun Rev 2008, 7(4):331-339.
2. Brown L.M., Gridley G., Check D., Landgren O. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood 2008, 111(7):3388-3394.
3. Trad S., Amoura Z., Haroche J., Huong Du Boutin L.T., Wechsler B., Leblond V., et al. Fatal progressive systemic sclerosis following autologous stem cell transplantation and high-dose chemotherapy. Rheumatology (Oxford) 2005, 44(7):951-953.
4. Čolović M., Jurisic V., Bila J., Čolović N., Palibrk V. FGF-R3 and OPG expression in patient with multiple myeloma following systemic sclerosis: case report and review of the literature. Int J Hematol 2011, 93(2):228-231.
5. McCudden C.R., Mathews S.P., Hainsworth S.A., Chapman J.F., Hammett-Stabler C.A., Willis M.S., et al. Performance comparison of capillary and agarose gel electrophoresis for the identification and characterization of monoclonal immunoglobulins. Am J Clin Pathol Mar 2008, 129(3):451-458.
6. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980, 23(5):581-590.
7. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T.A., et al. Scleroderma (systemic sclerosis); classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
8. LeRoy E.C., Medsger T.A. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001, 28:1573-1576.
9. Kyle R.A., Therneau T.M., Rajkumar S.V., Larson D.R., Plevak M.F., Offord J.R., et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 30 2006, 354:1362-1369.
10. Dispenzieri A., Katzmann J.A., Kyle R.A., Larson D.R., Melton L.J., Colby C.L., et al. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. Lancet 15 2010, 375(9727):1721-1728.
11. Broggini M., Cavallo A., Baratelli E., Volonté S., Crespi E., Cappelli A., et al. Monoclonal gammopathy of uncertain significance in rheumatic disease. Recenti Prog Med 1990, 81(5):306-309.
12. Elhai M., Avouac J., Kahan A., Allanore Y. Systemic sclerosis at the crossroad of polyautoimmunity. Autoimmun Rev 2013, 12(11):1052-1057.
13. Mehra S., Walker J., Patterson K., Fritzler M.J. Autoantibodies in systemic sclerosis. Autoimmun Rev 2013, 12(3):340-354.
14. Jimenez S.A., Piera-Velazquez S. Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome. Autoimmun Rev 2013, 12(11):1046-1051.
15. Kelly C., Baird G., Foster H., Hosker H., Griffiths I. Prognostic significance of paraproteinaemia in rheumatoid arthritis. Ann Rheum Dis 1991, 50(5):290-294.
16. Moutsopoulos H.M., Steinberg A.D., Fauci A.S., Lane H.C., Papadopoulos N.M. High incidence of free monoclonal lambda light chains in the sera of patients with Sjögren's syndrome. J Immunol 1983, 130(6):2663-2665.
17. Ali Y.M., Urowitz M.B., Ibanez D., Gladman D.D. Monoclonal gammopathy in systemic lupus erythematosus. Lupus 2007, 16(6):426-429.
18. Kaneko H., Endo T., Saitoh H., Katsuta Y., Aramaki T., Hayakawa H. Primary biliary cirrhosis associated with multiple myeloma. Intern Med 1993, 32(10):802-805.
19. Gilbrud B., Weiss P., Bakimer R., Shoenfeld Y. Identification and characterization of anti-mitochondrial autoantibodies in sera of patients with monoclonal gammopathies. Immunol Lett Mar 1995, 45(3):163-166.
20. von Landenberg P., Schölmerich J., Andreesen R., Vogelhuber M., Lackner K.J. A case of Waldenstroem's disease with a monoclonal IgM anti-phospholipid antibody. Rheumatol Int Jul 2002, 22(3):129-131. [Epub 2002 Jun 13].
21. Hanly J.G., Smith S.A. Autoimmune anti-phospholipid antibodies and cryoglobulinemia. Lupus 2000, 9(4):264-270.
22. Giuggioli D., Manfredi A., Colaci M., Manzini C.U., Antonelli A., Ferri C. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. Autoimmun Rev 2013, 12(11):1058-1063.
23. Villalta D., Imbastaro T., Di Giovanni S., Lauriti C., Gabini M., Turi M.C., et al. Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis. Autoimmun Rev 2012, 12(2):114-120.